Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Jubilant Therapeutics IncJubilant Therapeutics Inc
VS
RegeneronRegeneron
Jubilant Therapeutics Inc

Jubilant Therapeutics Inc

790, Township Line Road, Suite 175, Yardley, 19067, US

Last Update: 24/12/2025

View Profile
Between 750 and 799
http://www.jubilanttx.com
752/1000Fair

Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The company’s leadership and scientific team are science-driven exe...

NAICS:N/A
NAICS Definition:Others
Employees:13
Subsidiaries:13
12-month incidents
0
Known data breaches
0
Attack type number
0
Regeneron

Regeneron

777 Old Saw Mill River Road, Tarrytown, 10591, US

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.regeneron.com
819/1000Good

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new w...

NAICS:N/A
NAICS Definition:Others
Employees:16,502
Subsidiaries:2
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Jubilant Therapeutics Inc

Jubilant Therapeutics Inc

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Regeneron

Regeneron

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Jubilant Therapeutics Inc in 2026.

Incidents

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Regeneron in 2026.

Incidents

Incident History - Jubilant Therapeutics Inc (X = Date, Y = Severity)

Jubilant Therapeutics Inc cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Regeneron (X = Date, Y = Severity)

Regeneron cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Jubilant Therapeutics Inc

Jubilant Therapeutics Inc

Incidents
No explicit notable incidents reported.
Regeneron

Regeneron

Incidents
No explicit notable incidents reported.

FAQ

Between Jubilant Therapeutics Inc company and Regeneron company, which one has the best AI Cybersecurity Score ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced more cyber incidents in the past ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced more cyber incidents this year ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced at least one ransomware attack ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced at least one data breach ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced at least one targeted cyberattack ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has experienced at least one vulnerability ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one holds the most compliance certifications ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one holds the fewest compliance certifications ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has the most subsidiaries ?
Between Jubilant Therapeutics Inc company and Regeneron company, which one has the largest number of employees ?
Between Jubilant Therapeutics Inc and Regeneron, which company holds both SOC 2 Type 1 certifications ?
Between Jubilant Therapeutics Inc and Regeneron, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Jubilant Therapeutics Inc or Regeneron ?
Which company is PCI DSS compliant - Jubilant Therapeutics Inc or Regeneron ?
Between Jubilant Therapeutics Inc and Regeneron, which company complies with HIPAA regulations for healthcare data ?
Between Jubilant Therapeutics Inc and Regeneron, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-56078
SUMMARY

PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56077
SUMMARY

PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-56076
SUMMARY

PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-56075
SUMMARY

PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56074
SUMMARY

PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
CVSS4
Base Score: 6.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.8